| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | Nov 20, 2025 | Lexeo Therapeutics, Inc. | CEO | Sell | 43.8 | -1,127 | -0.47% | ✗ | $10.4K |
| Oct 15, 2025 | Oct 17, 2025 | Lexeo Therapeutics, Inc. | CEO | Sell | 90.0 | +19,867 | 8.94% | ✗ | $117.4K |
| Aug 18, 2025 | Sep 10, 2025 | Lexeo Therapeutics, Inc. | CEO | Sell | 37.5 | -1,115 | -0.50% | ✗ | $5.2K |
| Aug 18, 2025 | Aug 20, 2025 | Lexeo Therapeutics, Inc. | CEO | Sell | 26.3 | -2,735 | -1.23% | ✗ | $12.8K |
| May 16, 2025 | May 20, 2025 | Lexeo Therapeutics, Inc. | CEO | Sell | 45.0 | -1,074 | -0.48% | ✗ | $3K |
| Feb 19, 2025 | Feb 21, 2025 | Lexeo Therapeutics, Inc. | CEO | Sell | 26.3 | -4,326 | -1.93% | ✗ | $19.1K |
| Dec 10, 2024 | Dec 12, 2024 | Lexeo Therapeutics, Inc. | CEO | Sell | 45.0 | -2,500 | -2.03% | ✓ | $20.5K |
| Nov 11, 2024 | Nov 13, 2024 | Lexeo Therapeutics, Inc. | CEO | Sell | 45.0 | -2,500 | -2.03% | ✓ | $19.6K |
| Oct 10, 2024 | Oct 15, 2024 | Lexeo Therapeutics, Inc. | CEO | Sell | 41.3 | -5,000 | -3.98% | ✓ | $40.5K |
| Sep 10, 2024 | Sep 11, 2024 | Lexeo Therapeutics, Inc. | CEO | Sell | 37.5 | -5,000 | -3.98% | ✓ | $53.3K |
| Aug 12, 2024 | Aug 13, 2024 | Lexeo Therapeutics, Inc. | CEO | Sell | 37.5 | -5,000 | -3.98% | ✓ | $57.6K |
| Jul 10, 2024 | Jul 12, 2024 | Lexeo Therapeutics, Inc. | CEO | Sell | 7.5 | -55,000 | -31.30% | ✓ | $923.4K |
| Jun 10, 2024 | Jun 12, 2024 | Lexeo Therapeutics, Inc. | CEO | Sell | 41.3 | -5,000 | -2.85% | ✓ | $88.3K |
| May 13, 2024 | May 14, 2024 | Lexeo Therapeutics, Inc. | CEO | Sell | 41.3 | -5,000 | -2.85% | ✓ | $66.1K |